Hepatitis C Virus (HCV) Updates: Recommendations for Managing and Treating Hepatitis C
In the United States, more than 2.4 million people have a diagnosis of Hepatitis C Virus. Hepatitis C is a contagious liver disease spread through contact with the blood of a person who has the virus. It can result in serious liver damage, including liver failure. There are different types of Hep C, called genotypes. Genotypes 1-6 are the most common. Knowing which genotype patients have is important for their treatment. Understanding how to monitor the medications for hepatitis C and the duration of therapy of the medications will help pharmacists and pharmacy technicians be able to track if a medication is effective for a patient. Healthcare professionals will know what to look out for in terms of each medication’s monitoring parameters in order to ensure a better safety profile for the patients. The presentation will cover the updates in treatment options available for Hepatitis C. The focus of this presentation will be to evaluate and discuss the evidence supporting the evidence of Hepatitis C treatment updates. The evidence will be applied to patient cases to assess learning.
Target Audience
- Pharmacists
- Pharmacy technicians
Learning Objectives
Pharmacist learning objectives
- Recall how to design a treatment plan for initial Hepatitis C virus (HCV) patients based on updates with a focus on shortened duration of glecaprevir/pibrentasir treatment and elimination of renal adjustments for sofubuvir-based regimens
- Describe how to manage HCV in the pediatric population according to updated guidelines and FDA package labels
Pharmacy technician learning objectives
- Discuss Hepatitis C virus (HCV) transmission and define pertinent lab values
- Recognize brand/generic names of medications discussed in the updated guidelines and applicable package inserts
Additional Information
Attachment | Size |
---|---|
![]() | 23.3 KB |
![]() | 123.19 KB |
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
PLANNING COMMITTEE MEMBERS
COURSE REVIEWER
PRESENTER

Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CEU – Attendance